HF
BNGO icon

HRT Financial’s Bionano Genomics BNGO Stock Holding History

HRT Financial’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,330
Closed -$34K – 3213
2025
Q3 		$34K Buy
+20,330
New +$64.6K ﹤0.01% 2639
2024
Q2 		– Sell
-350
Closed -$23K – 2257
2024
Q1 		$23K Buy
+350
New +$26.1K ﹤0.01% 1997
2023
Q3 		– Sell
-81
Closed -$29K – 2425
2023
Q2 		$29K Buy
81
+63
+350% +$28.4K ﹤0.01% 2067
2023
Q1 		$12K Buy
+18
New +$16K ﹤0.01% 2234
2022
Q2 		– Sell
-46
Closed -$70K – 2963
2022
Q1 		$70K Buy
46
+29
+171% +$39.1K ﹤0.01% 2713
2021
Q4 		$31K Buy
+17
New +$45.5K ﹤0.01% 2901
2021
Q2 		– Sell
-1,552
Closed -$7.52M – 2866
2021
Q1 		$7.52M Buy
+1,552
New +$8.75M 0.08% 187

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return

HRT Financial's BNGO Position: Q4 2025 in Review

HRT Financial sold out of Bionano Genomics (BNGO) in Q4 2025, closing a stake of 20,330 shares — an estimated $34K sold.

HRT Financial first reported a position in BNGO in Q1 2021 and held it in 7 quarters. The position peaked at $7.52M in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

  • HRT Financial reported no remaining Bionano Genomics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 20,330 Bionano Genomics shares in Q4 2025, an estimated $34K.
  • HRT Financial first reported a position in Bionano Genomics in Q1 2021 and held it in 7 quarters.
  • HRT Financial's Bionano Genomics position peaked at $7.52M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.